(4-Aminopiperidin-1-yl)(2-nitrophenyl)methanone hydrochloride

Catalog No.: 
ACTRXU227
CAS No.: 
1158501-49-5
Molecular Formula: 
C12H16ClN3O3
Molecular Weight: 
285.73
(4-Aminopiperidin-1-yl)(2-nitrophenyl)methanone hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%
1g97%
5g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-Aminopiperidin-1-yl)(2-nitrophenyl)methanone hydrochloride
IUPAC Name(4-aminopiperidin-1-yl)(2-nitrophenyl)methanone hydrochloride
MDL No.MFCD08690149
Molecular FormulaC12H16ClN3O3
Molecular Weight285.73
SMILESO=C(N1CCC(N)CC1)C2=CC=CC=C2[N+]([O-])=O.[H]Cl
InChI KeyFKQKRUUSFYPUJG-UHFFFAOYSA-N
Synonym(4-AMINO-PIPERIDIN-1-YL)-(2-NITRO-PHENYL)-METHANONE HYDROCHLORIDE;Methanone, (4-amino-1-piperidinyl)(2-nitrophenyl)-, hydrochloride
CAS No.1158501-49-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTRXU227 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACTRXU227 route product structure diagram
    ACTRXU2271158501-49-5
Inquiry

2. ACTRXU227 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRXU227 route product structure diagram
    ACTRXU2271158501-49-5
Inquiry

3. ACTRXU227 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTRXU227 route product structure diagram
    ACTRXU2271158501-49-5
Inquiry

Comments (0)